Market research
CROX Crocs Inc
NASDAQ USD Consumer Cyclical
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 6B
- P/E ratio
- 10.84
- Analyst target
- 138.25
- Dividend yield
- Not available
- Beta
- 1.53
Profile
Company facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Consumer Cyclical
- Industry
- Footwear & Accessories
- ISIN
- US2270461096
- Market cap
- 6B
- P/E ratio
- 10.84
- Analyst target
- 138.25
- Dividend yield
- Not available
- Beta
- 1.53
About
About Crocs Inc
Crocs, Inc. together with its subsidiaries, designs, develops, manufactures, markets, distributes, and sells casual lifestyle footwear and accessories for men, women, and kids under the Crocs and HEYDUDE Brands in the United States and internationally. The company offers various footwear products, including clogs, sandals, loafers, classics, fuzz, platforms, boots, sandals, slides, slippers, sneakers, flip flops, and flats, as well as totes, backpacks, belt bags, socks, bag charms, cases, attachments, cartoon characters products, and touchland and other accessories. It sells its products through wholesalers, retail stores, e-commerce sites, third-party marketplaces, outlet stores, and kiosks/store-in-store locations. Crocs, Inc. was founded in 1999 and is headquartered in Broomfield, Colorado.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the CROX discussion.
5 years, 4 months ago
Crocs, Inc is currently in a long term uptrend where the price is trading 44.8% above its 200 day moving average.
From a valuation standpoint, the stock is 95.7% cheaper than other stocks from the Consumer Cyclical sector with a price to sales ratio of 4.0.
Crocs, Inc's total revenue rose by 56.5% to $412M since the same quarter in the previous year.
Its net income has increased by 820.7% to $183M since the same quarter in the previous year.
Finally, its free cash flow grew by 662.1% to $99M since the same quarter in the previous year.
Based on the above factors, Crocs, Inc gets an overall score of 5/5.